SHANGHAI, Jan. 2, 2024 /PRNewswire/ — YolTech Therapeutics, a biotech company developing in vivo gene editing therapies to treat rare genetic diseases, recently announced that it will present an overview of its technology and provide corporate updates on key programs at Biotech Showcase,…